Emerging erythromycin and clindamycin resistance in group A streptococci: Efficacy of linezolid and tedizolid in experimental necrotizing infection

Objectives: Clindamycin (CLI) and erythromycin (ERY) resistance is increasing among group A streptococci (GAS) causing invasive disease and alternative treatments are urgently required. In this study, the efficacy of the newer oxazolidinone tedizolid (TZD) was compared with the first drug in this cl...

Descripció completa

Dades bibliogràfiques

Autors principals:	Amy E. Bryant, Clifford R. Bayer, Michael J. Aldape, Eric McIndoo, Dennis L. Stevens
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2020-09-01
Col·lecció:	Journal of Global Antimicrobial Resistance
Matèries:	Group A streptococcus GAS Streptococcus pyogenes Myonecrosis Antibiotic treatment Oxazolidinone
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2213716520301235
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!